Extraperitoneal cystectomy with ureterocutaneostomy derivation in fragile patients - should it be performed more often?
https://doi.org/10.4081/aiua.2022.2.144
Accepted: April 16, 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Introduction and objectives: Radical cystectomy (RC) continues to be standard of care for muscle-invasive bladder cancer and recurrent or refractory nonmuscle invasive bladder cancer. Unfortunately, it has high rates of perioperative morbidity and mortality. One of the most important predictors of postoperative outcomes is frailty, while the majority of complications are diversion related. The aim of our study was to evaluate safety of extraperitoneal cystectomy with ureterocutaneostomy in patients considered as frail. Materials and methods: We retrospectively collected data of frail patients who underwent extraperitoneal cystectomy with ureterocutaneostomy from October 2018 to August 2020 in a single center. We evaluated frailty by assessing patients' age, body mass index (BMI), nutritional status by Malnutrition Universal Screening Tool, overall health by RAI (Risk Analysis Index) and ASA (American Society of Anaesthesiologists) score, and laboratory analyses. We observed intraoperative outcomes and rates of perioperative (within 30 days) and early postoperative (within 90 days) complications (Clavien-Dindo classification). We defined extraperitoneal cystectomy with ureterocutaneostomy as safe if patients did not develop Clavien Dindo IIIb, or worse, complication. Results: A total of 34 patients, 3 female and 31 male, were analyzed. The median age was 77, BMI 26, RAI 28, ASA 3 and the majority had preexisting renal insufficiency. Blood analyses revealed presence of severe preoperative hypoalbuminemia and anemia in half of our cohort. Intraoperative median blood loss was 250 cc, whilst operative time 245 min. During perioperative period 60% of our cohort developed Clavien Dindo II complication and during early postoperative period 32% of patients required readmission. One death occurred during early postoperative period (2.9%). After 12 months of follow-up, we observed stability of the renal function for most patients. Conclusions: We believe that extraperitoneal cystectomy with ureterocutaneostomy could be considered as a treatment option for elderly and/or frail patients.
EAU Non-muscle-invasive Bladder Cancer 2021 guidelines, https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/.
Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Guerin. Eur Urol. 2016; 69:60-9. DOI: https://doi.org/10.1016/j.eururo.2015.06.045
Fedeli U, De Paoli A, Corti MC, et al. Perioperative mortality and long-term survival after radical cystectomy: a population-based study in a Southern European country on 4,389 Patient. Urol Int. 2020; 104:559-566. DOI: https://doi.org/10.1159/000506240
Schuurmans H, Steverink N, Lindberg S, et al. Old or frail: what tells us more? J Gerontol A Biol Sci Med Sci 2004; 59:M962-5. DOI: https://doi.org/10.1093/gerona/59.9.M962
Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action J Am Med Dir Assoc 2013; 14:392-7 DOI: https://doi.org/10.1016/j.jamda.2013.03.022
Fried LP, Tangen CM, Walson J, et al. Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci. 2001; 56:M146-156. DOI: https://doi.org/10.1093/gerona/56.3.M146
Khan KT, Hemati K, Donovan AL. Geriatric physiology and the frailty syndrome Anesthesiol Clin. 2019; 37:453-474. DOI: https://doi.org/10.1016/j.anclin.2019.04.006
Berger I, Wehrberger C, Ponholzer A, et al. Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older Urol Int 2015; 94:394. DOI: https://doi.org/10.1159/000367853
Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate J Urol 2010; 184: 990. DOI: https://doi.org/10.1016/j.juro.2010.05.037
Drudi ML, Ades M, Landry T, et al. Scoping review of frailty in vascular surgery J Vasc Surg. 2019; 69:1989-1998.e2. DOI: https://doi.org/10.1016/j.jvs.2018.10.053
Sioutas G, Tsoulfas G. Frailty assessment and postoperative outcomes among patients undergoing general surgery Surgeon. 2020; 18:e55-e66. DOI: https://doi.org/10.1016/j.surge.2020.04.004
Hirpara HD, Kidane B, Rogalla P, et al. Frailty assessment prior to thoracic surgery for lung or esophageal cancer: a feasibility study. Support Care Cancer. 2019; 27:1535-1540. DOI: https://doi.org/10.1007/s00520-018-4547-9
Cawood AL, Walters ER, Sharp SKE, et al. Self-screening' for malnutrition with an electronic version of the Malnutrition Universal Screening Tool ('MUST') in hospital outpatients: concurrent validity, preference and ease of use. Br J Nutr. 2018; 120:528-536. DOI: https://doi.org/10.1017/S000711451800185X
Melin AA, Schmid KK, Lynch TG, et al. Preoperative frailty Risk Analysis Index to stratify patients undergoing carotid endarterectomy. J Vasc Surg. 2015; 61:683-9. DOI: https://doi.org/10.1016/j.jvs.2014.10.009
https://www.asahq.org/standards-and-guidelines/asa-physicalstatus-classification-system.
TNM classification of malignant tumors. UICC International Union Against Cancer. 8th edn., G.M. Brierley JD, Wittekind C., Editor. 2017, Wiley-Blackwell and UICC: New York, USA.
Clavien PA, Barkun J, de Oliveira ML, et al. 'The Clavien-Dindo classification of surgical complications: five year experience' Ann Surg. 2009; 250:187-96. DOI: https://doi.org/10.1097/SLA.0b013e3181b13ca2
Yadav S, Rawal G, Baxi M. Vacuum assisted closure technique: a short review. Pan Afr Med. 2017; 28:246. DOI: https://doi.org/10.11604/pamj.2017.28.246.9606
Maisch P, Lunger L, Duwel C, et al. Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer. Urol Oncol. 2021; 39:368.e11-368.e17. DOI: https://doi.org/10.1016/j.urolonc.2020.11.042
Gild P, Nguyen DD, Fletcher SA, et al. Contemporary survival rates for muscle-invasive bladder cancer treated with definitive or nondefinitive therapy. Clin Genitourin Cancer. 2019; 17:e488-e493. DOI: https://doi.org/10.1016/j.clgc.2019.01.009
Ploussard G, Daneshmand S, Efstathiou JA, et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.Eur Urol 2014; 66:120-137. DOI: https://doi.org/10.1016/j.eururo.2014.02.038
Jewett HJ, Lewis EL. Infiltrating carcinoma of the bladder; curability by total cystectomy. J Urol. 1948; 60:107-118. DOI: https://doi.org/10.1016/S0022-5347(17)69206-1
Llorente C, Guijarro A, Hernandez V, et al. Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain. World J Urol. 2020; 38:1221-1228. DOI: https://doi.org/10.1007/s00345-019-02874-9
Afshar M, Goodfellow H, Jackson-Spence F, et al. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the ‘Improving Outcomes Guidance’: the case for super centralisation. BJU Int. 2018; 121:217-224. DOI: https://doi.org/10.1111/bju.13929
Williams SB, Huo J, Kosarek CD, et al. 'Population-based assessment of racial/ ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer' Cancer Causes Control. 2017; 28:755-66. DOI: https://doi.org/10.1007/s10552-017-0902-2
Nieuwenhuijzen JA, de Vries RR, Bex A, et al. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol. 2008; 53:834-44. DOI: https://doi.org/10.1016/j.eururo.2007.09.008
Longo N, Imbimbo C, Fusco F, et al. Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy. BJU Int. 2016; 118:521-6. DOI: https://doi.org/10.1111/bju.13462
De Nunzio C, Cicione A, Leonardo F, et al. Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians. Int Urol Nephrol 2011; 43:663-667. DOI: https://doi.org/10.1007/s11255-010-9876-7
Kavukoglu Ö, Coskun A, Sabuncu K, et al. Is it possible to reduce the complications and mortality of patients undergoing radical cystectomy? Effectiveness of pre-operative parameters. A prospective study. Arch Ital Urol Androl. 2021; 93:379-384. DOI: https://doi.org/10.4081/aiua.2021.4.379
Maffezzini M, Fontana V, Pacchetti A, et al. Age above 70 years and Charlson Comorbidity Index higher than 3 are associated with reduced survival probabilities after radical cystectomy for bladder cancer. Data from a contemporary series of 334 consecutive patients. Arch Ital Urol Androl. 2021; 93:15-20. DOI: https://doi.org/10.4081/aiua.2021.1.15
Mayr R, Gierth M, Zeman F, et al. Sarcopenia as a comorbidityindependent predictor of survival following radical cystectomy for bladder cancer. J Cachexia Sarcopenia Muscle 2018; 9:505-13. DOI: https://doi.org/10.1002/jcsm.12279
Mantica G, Smelzo S, Ambrosini F, et al. Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences. J Robot Surg. 2020; 14:805-812. DOI: https://doi.org/10.1007/s11701-020-01062-x
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
